Patent · US Active

Floating gastric retentive dosage form

US9314430B2 · kind B2 · utility

1Cited by

4References

15Claims

0Family size

Assignee

JAGOTEC AG · CH

Inventors

Pascal Grenier · Ségny, FR
Alain Nhamias · Bartenheim, FR
Guy Vergnault · Rixheim, FR

Key dates

Filing date	Jul 4, 2011
Grant date	Apr 19, 2016
Priority date	—
Expiry date	Jun 11, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M31/002
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An elongate dosage form of generally cylindrical shape having two opposing ends, the dosage form being buoyant in. gastric fluid, wherein the dosage form is weight biased such that. one end is heavier than the ether end. The dosage form is adapted to float on gastric fluid with its long axis substantially perpendicular to the surface of the: fluid with its heavier end pointing: generally; downwards and into the fluid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.